anti-GD2-800CW

DRUG2 trials

Sponsors

Prinses Maxima Centrum voor Kinderoncologie B.V., Princess Maxima Center for Pediatric Oncology

Conditions

Neuroblastoma

Phase 1

GLOW-FISH: A phase Ib/II first-in-human imaging study of anti-GD2-800CW in patients with neuroblastoma.

RecruitingCTIS2023-507596-22-00

Prinses Maxima Centrum voor Kinderoncologie B.V.Neuroblastoma

Start: 2025-11-05Target: 22Updated: 2025-10-17

An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma

RecruitingNCT07399821

Princess Maxima Center for Pediatric OncologyNeuroblastoma

Start: 2025-11-05End: 2027-05-01Target: 22Updated: 2026-02-10